DE|EN
Select your region & language
Our content and services may vary by location.
DE|EN
Back
Smiling employee in a conversation with a colleague in the office
Smiling employee in a conversation with a colleague in the office
ID: 127143

Interim Sales Director & Strategy Consultant

  • MedTech
  • Asap
  • Corporate Restructuring / Turnaround, Sales
  • K-Recruiting GmbH
Contact:

Julius Strack

+49 89 1890998-21

julius.strack@k-recruiting.com

Overview

Availability
Asap, 5 days/week, on-site & remote
Qualification
Retail Salesman
Language Skills
German & English (native)
Relevant Expertise
Corporate Restructuring / Turnaround, Post-Merger Integration Management, Sales Leadership and Optimization, Internationalization, Sales Controlling, Cost Optimization, Protection of Owner Assets, Medical Device, Life Science

Key-Facts

  • Specialized in turnaround, corporate restructuring, digital transformation (including AI Prompt Engineering), and sales leadership across healthcare (MedTech, BioTech, hospital management) and industrial sectors

  • Translates strategies into outcomes: motivated high-performance teams, optimized costs, increased revenues, higher enterprise value, and sustainable profitability

  • Strong capabilities in leadership, communication, and motivation – fostering trust, resilience, and a positive, learning-oriented corporate culture

  • Over 30 years of executive leadership, more than 20 successful restructurings as CEO, CRO, and CSO; expertise in international markets (US Government Sales, EMEA, Asia) and recognized UK specialist after 12 years in London

Extract from Previous Activities

2024 – 2025

Medical Device Company, Germany

Interim CSO

  • Post-merger revenue decline and underperforming locations

  • Turnaround of the sales organization

  • Restructuring Sales, Marketing, Key Account Management, and Customer Service; complete replacement of the sales team

  • Increased field sales efficiency by 67%

  • Reduced prescription billing errors by 80%

  • Reduced number of non-paying customers from 89 to 39

  • Improved telemarketing performance from 90.50% to 96.20%

  • Integrated 8 subsidiaries

  • Acquired 252 new customers

  • Regained 7 lost key accounts

  • Generated additional new revenues of €8.2 million

  • Stabilized organizations at employee level

2024

Chemical Industry, Germany

Restructuring Consultant

  • Over-indebtedness due to revenue decline

  • Rented out an unused property, generating additional income of €300K p.a.

  • Executed a sale & leaseback transaction of a property

  • Identified and secured an investment partner / successor

2023 – 2024

Medical Device Company, Germany

Interim CRO

  • Secured and continued production

  • Achieved sales proceeds from inventory, real estate, and asset deals 60% above expectations

  • Reached the highest revenue growth in company history at +21%

  • Delivered record EBITDA margin

  • Achieved the highest order intake in company history, up +167%

  • Reduced absenteeism rate from 7.2% to 6.1%

  • Increased EBITDA by +35.8%

  • Improved EBITDA margin by +4.3%

  • Implemented price increase of +14%

2023

Medical Device Company, Germany

IDW S6 Restructuring Expert

  • Hospital and Nursing Home Operator

  • Restructuring case

  • Prepared an IDW S6 restructuring report

  • Developed a comprehensive restructuring plan focusing on: Corporate planning, Consolidation and closure of business units, Business modelling / core processes, Financial analysis

2023

Electronic Industry, Austria

Strategy Consultant

  • Organization of Trade Finance and Factoring

  • Developed a professional pitch deck for investors

  • Prepared a business plan for banks

2023

Medical Device Company, Switzerland

Strategy Consultant

  • Company seeking to acquire a manufacturer – preparation, due diligence, and support in sales negotiations

  • Prepared a pitch document and takeover offer for a competitor company

2023

Medical Device Company, Austria

Strategy Consultant

  • Following a billing fraud incident, the entire staff had to be replaced and all processes reviewed and restructured

  • Significantly relieved the business owner from operational burden

  • Replaced 80% of the staff

  • Established all processes and ensured compliance adherence

2022

Medical Device Company, Switzerland

Interim CEO

  • Loss of approx. 57% of revenue, management, personnel, and quality deficiencies

  • Replaced 40% of staff and developed high-potential employees

  • Resolved quality issues at the India plant and secured the supply chain

  • Restructured and doubled sales through internationalization

  • Acquired the largest single customer in the company’s history

2019 – 2021

Medical Device Company, USA

Interim Director Int. Sales

  • Development of an international sales organization, market entry & penetration, partner and key account development, and international marketing

  • Doubled revenue from 2020 to 2021

  • Achieved all-time-high sales in Denmark, Norway, Russia, and Austria

  • Closed the largest single order in the company’s history

2017 – 2019

Medical Device Company, Germany

Interim Global Sales Director

  • Insufficient revenue, oversized and misaligned corporate structure

  • Executed post-acquisition integration and consolidation at the Cairo site

  • Optimized production and logistics processes

  • Restructured sales and opened numerous new markets in EMEA, increasing revenue by 85%

2016 – 2017

Medical Device Company, Austria

Interim CEO/CRO

  • Complete Corporate Restructuring

  • Guided the company through a structured insolvency process

  • Executed the sale of the company to a private equity firm